Using Smartphone Technology to Help Older Adults with Mild Cognitive Impairment Manage High Blood Pressure Medications

What this Trial Is About

Researchers are evaluating a smartphone technology called bpMedManage to improve medication adherence for high blood pressure in older adults with mild cognitive impairment MCI. This 16-week randomized controlled trial will include 100 participants aged 60 and older. The study compares two groups to see how well the smartphone tools support taking blood pressure medications as prescribed. Participants will first complete baseline assessments and 4 weeks of medication adherence monitoring. After this, they will be randomly assigned to one of two groups the bpMedManage-S group, which uses a smartphone app with medication reminders plus educational materials about hypertension and medications or the bpMedManage-P group, which uses the smartphone only to access educational materials. Both groups will be assessed for immediate outcomes 4 weeks after starting the intervention and again at 12 weeks for follow-up. During the study, participants will use their smartphones and complete various assessments including medication adherence measured by electronic monitoring and self-report. Blood pressure readings and knowledge about hypertension will also be evaluated. Participants will be monitored for usability of the system and followed for a total of 16 weeks. The research aims to measure changes in medication adherence and related health outcomes over this period.

bpMedManage: Digital Technology to Support Adherence to Hypertension Medications